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Abstract
Polyhydroxyalkanoates (PHAs) are biodegradable polymers produced by microbes to overcome
environmental stress. Commercial production of PHAs is limited by the high cost of production
compared to conventional plastics. Another hindrance is the brittle nature and low strength of
polyhydroxybutyrate (PHB), the most widely studied PHA. The needs are to produce PHAs, which
have better elastomeric properties suitable for biomedical applications, preferably from
inexpensive renewable sources to reduce cost. Certain unique properties of Bacillus subtilis such as
lack of the toxic lipo-polysaccharides, expression of self-lysing genes on completion of PHA
biosynthetic process – for easy and timely recovery, usage of biowastes as feed enable it to
compete as potential candidate for commercial production of PHA.
Background
The natural bioploymers
Polyhydroxyalkanote(s) (PHAs) are natural biopolymers.
Many prokaryotic organisms accumulate PHAs as reserve
material when carbon (C) source is available in excess in
the environment and there is a limitation of nutrients
essential for growth. It serves as a food source, which is
mobilized by PHA depolymerase under stressed environ-
mental conditions [1]. Although PHAs may generally
account upto 90% of the dry cell weight (DCW) of the
microbes [2], however their production on industrial
scale is still very costly in comparison to petrochemical-
based plastics [3,4]. The other basic drawbacks which
hinder their exploitation on industrial scale are the highly
crystalline nature and very low strength of poly(3-
hydroxybutyrate) (PHB), the most well studied PHA. In
contrast to homopolymers of 3HB (PHBs), copolymers of
small chain length C3-C5 hydroxy acids (scl-HA) and
medium chain length C6-C14 mcl-HA of PHA are more
ductile, easier to mold and tough [5]. These copolymers
have better film forming and mechanical properties quite
similar to low-density polyethylene. These features
improve their strength and processability [6,7]. Certain
microbes can even produce a natural-synthetic hybrid
block copolymer of polyhydroxyoctanoate-diethylene
glycol, which results in significant changes in their physi-
ochemical and material characteristics [8,9]. Efforts are
thus needed towards improving product quality [10] and
efficiency of the recovery process, which will result in opti-
mization of yields. In order to reduce the cost of produc-
tion, efforts are being made to search [11,12] or develop
(genetically engineered) strains [13] capable of producing
PHAs from inexpensive renewable sources [5,14,15], or
even develop transgenic plants for this purpose [16]. The
purpose of this review is primarily to consolidate the fea-
tures of Bacillus subtilis as a potential candidate for produc-
ing biopolymers – PHAs.
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PHA biosynthesis and producers
The classical PHB biosynthetic pathway consists of reac-
tions catalyzed by three distinct enzymes. The initial reac-
tion involves condensation of two acetyl-CoA molecules
to form acetoacetyl-CoA, which is catalyzed by β-ketothi-
olase (encoded by phaA). The second step is the reduction
of acetoacetyl-CoA by an NADPH-dependent acetoacetyl-
CoA dehydrogenase (encoded by phaB). Lastly, the (R)-3-
hydroxybutyryl-CoA monomers are polymerized into
P(3HB) by P(3HB) synthase (encoded by phaC) [3]. In
addition, some PHA producers use secondary pathways: i)
methylmalonyl CoA pathway, ii) the de novo fatty acid
synthetic pathway and iii) via a five-step metabolic path-
way assisted by two stereospecific 2-enoyl-CoA hydratases
prior to polymerization [5].
Of the three genes generally reported to be involved in
PHA biosynthesis, phaA and phaB genes are also involved
in glyoxylate regeneration in certain α-Proteobacteria and
Actinobacterium. In addition, phaA gene is also involved
in the synthesis of mevalonate, which is ubiquitously
present in plants. The transfer of phaC gene into an organ-
ism gives a new dimension to the functioning of phaA and
phaB genes, which occur together at a much higher fre-
quency in different organisms than with phaC gene [17].
PHA synthases belonging to the α/β hydrolase super-
family from 45 different bacteria show an overall identity
of 8 to 96%. These could be grouped into 4 different
classes [1]: Class I and II PhaC, made up of one subunit
(61 to 73 kDa) could produce scl-PHAs (in Ralstonia
eutropha) and mcl-PHAs (in Pseudomonas aeruginosa),
respectively. Class III PHA synthases reported from Allo-
chromatium vinosum have two types of subunits: i) PhaC
and ii) PhaE (approximately 40 kDa each) which prefera-
bly synthesize scl-PHAs. Class IV PHA synthases, which
resemble Class III PHA synthases (PhaE is replaced by a 20
kDa PhaR) have been reported only in Bacillus spp. [1].
A perusal of the capacities of different microbes to pro-
duce PHAs reveals that certain Gram-negative bacterial
species belonging to Alcaligenes,  Ralstonia  and  Pseu-
domonas lead this group. Alcaligenes and Ralstonia are ver-
satile organisms with well established abilities to utilize
pure substrates, agricultural wastes, oily wastes, dairy
products and carbon dioxide (CO2) for PHA production
[5,18-20]. Pseudomonas can normally synthesize mcl-PHA
on various aliphatic alkenes or fatty acids, agricultural and
oily wastes [20,21]. Pseudomonas sp. can however, simul-
taneously produce scl-mcl PHAs [22-26]. Among the
Gram-negative bacteria, certain archaeal strains of Halof-
erax, Halobacterium, Haloarcula and Haloquadratum have
been reported for their abilities to synthesize PHA from
inexpensive C sources as feed material [27,28]. Although
Gram-positive bacteria have not been widely studied, a
few genera reported to produce PHB and certain copoly-
mers include Bacillus, Clostridium, Corynebacterium, Nocar-
dia, Rhodococcus, Streptomyces and Staphylococcus [29].
Bacillus as PHA producer
B. subtilis is generally regarded as safe (GRAS) organism by
Food and Drug Administration (FDA) [30,31] and thus
offers additional benefits. B. subtilis has been accorded the
designation of industrial workhorse for being among the
most widely used microbes for large scale production of
recombinant proteins, amino acids and fine chemicals
[32,33]. It will not be inappropriate to call them as "cell
factory" [34] since B. subtilis is already known for produc-
tion of valuable metabolites, bioremediation and genera-
tion of bioenergy [35-37] but much attention has not
been paid to them as PHA producers. Among the Bacillus
spp. reported to be PHA producers, the PHA yields vary
from 11 to 69% (w/w of DCW – upto 70 g/L): B. amyloliq-
uefaciens DSM7, B. laterosporus, B. licheniformis, B. macer-
ans, B. cereus, B. circulans, [6], B. firmus G2, B. subtilis K8,B.
sphaericus X3, B. megaterium Y6 [38], B. coagulans, B. brevis,
B. sphaericus ATCC 14577 [39], B. thuringiensis [37], B.
mycoides RLJ B-017 [40] and Bacillus sp. JMa5 [41]. Bacillus
sp. INT005 and B. cereus UW85 could produce PHA with
a wide range of compositions varying from PHB, P(3HB-
co-3HV: copolymer of butyrate and valerate), P(3HB-co-
3HHx: copolymer of butyrate and hexanoate), P(3HB-co-
4HB-co-3HHx: copolymer of 3-hydroxy-, 4-hydroxy-
butyrates and hexanoate) to P(3HB-co-6HHx-co-3HHx:
terpolymer of butyrate, 6-hydroxy- and 3-hydroxy hex-
anoates) depending upon the substrate [42,43]. Various
Bacillus spp. have been shown by different researchers to
synthesize copolymers when co-fed with various sub-
strates. Using B. cereus UW85, the production of terpoly-
mer of 3HB, 3HV and 6HHx was recorded with ε-
caprolactone as sole C source in mineral salts medium
without any glucose. However, addition of glucose along
with ε-caprolactone seemed to suppress copolymer syn-
thesis and the result was the production of PHB [42].
Bacillus sp. INT005 could accumulate PHB when glucose
was used alone as C substrate in the medium. However,
addition of various C sources along with very low glucose
concentration resulted in copolymers of 3HB and 3HHx
on octanoate and decanoate, copolymers of 3HB-4HB-
4HHx on 4-hydroxybutanoate and 3HB-3HHx-6HHx on
supplementation with ε-caprolactone [44]. Recent studies
have produced still more interesting information. B. cereus
SPV when grown on structurally unrelated C sources such
as fructose, sucrose and gluconate resulted in the incorpo-
ration of 4HB with the first two substrates and 4HB and
3HV with gluconate in the medium [45]. Although limita-
tion of nitrogen (N), phosphorous (P) and oxygen in the
culture conditions are known to influence PHB produc-
tion, however, potassium limiting media led to the pro-
duction of a copolymer containing 3HB and 3HV
monomers in contrast to only PHB under sulphur, P or NMicrobial Cell Factories 2009, 8:38 http://www.microbialcellfactories.com/content/8/1/38
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limitation [43]. B. megaterium yielded PHB on cane
molasses [46], B. cereus CFR06 on starch [47] and other
Bacillus spp. could also produce PHB from industrial food
waste water, soya waste and malt waste from beer brewery
plant and pea-shell slurry [48]. Bacillus sp. 256 utilize an
unrefined natural substrate – mahua (Madhuca sp.) flower
as C source (containing 57% w/w as sugars) to produce
copolymers (90:10 mol% P(HB-co-HV)) [49].
There are a few reports which have shown B. subtilis to be
natural producers [37-39,50]. These results need to be
viewed more cautiously since B. subtilis is a very heteroge-
neous group. Recent studies have shown that B. subtilis
can be subdivided into two subspecies namely B. subtilis
subsp.subtilis and B. subtilis subsp.spizizenii [51,52], such
that only one of them may possess members which are
PHA producers, where as those belonging to B. subtilis
subsp. subtilis (B. subtilis 168 belongs to this group) may
be naturally non-producers types. This results in a very
interesting situation with respect to B. subtilis, which can
thus be "labeled" as non-producers just like Escherichia coli
which has been widely used for expression of many genes
including those of PHA biosynthesis [3,5,53-56].
B. subtilis has been recently used as a host for over expres-
sion of phaCAB genes from P. aeruginosa and R. eutropha.
Expression of phaC1 from P. aeruginosa and phaAB genes
from R. eutropha in B. subtilis resulted in the production of
copolymers P(HD-co-HDD, hydroxydecanoate-co-
hydroxydodecanoate) and P(HB-co-HD-co-HDD) from
malt waste [57]. Since B. subtilis is not a human pathogen,
further supporting its usage as a host for expression of for-
eign genes [58]. B. megaterium phaPQRBC genes were
cloned into B. subtilis 1A304(Φ105MU331). This report of
stable plasmid integration into the B. subtilis chromosome
paved the way for large scale fermentation process for pro-
duction of PHA which eliminated the use of antibiotics, a
desirable feature for reducing production cost [58].
Recombinant B. subtilis could utilize malt waste as a C
source, further raising the hopes for producing PHA at
cheaper rates. This study showed that phaPQ of B. megate-
rium  were essential for PHA production along with
phaRBC, although they could not observe any sequence
homology in NCBI database. It has been previously
shown that phaP in R. eutrophus might play a role in deter-
mining the shape and size of the inclusion bodies [59].
Although B. subtilis has the potential to compete with E.
coli, the most commonly used host for heterologous
expression of genes [34] and it may even be superior in
certain aspects, however, the time pressure limits the
change of host organism in later stages of development of
process optimization [60]. Westers et al., [60] listed four
drawbacks in using Bacillus as host organism – a) lack of
suitable expression vectors, b) plasmid instability, c) pres-
ence of protease and d) presence of malfolded proteins.
Recent efforts have circumvented certain issues such as the
generation of suitable expression vectors [61] and stable
plasmids particularly for PHA production [58]. B. subtilis
WB800 strain lacking eight extracellular proteases enabled
the production of homologous proteins, including those
which were otherwise susceptible to rapid degradation
[34]. Certain other features which further support B. sub-
tilis as potential PHA producer have been discussed here.
Genomic status of PHA biosynthesis in Bacillus
In the post genomic era, 22 Bacillus  strains have been
sequenced and 32 projects are in progress [62]. Among all
Bacillus spp., B. subtilis is one of the most heterogeneous
representative [52,63,64]. The concerted efforts of Euro-
pean Union funded consortia [65-67] lead B. subtilis [68]
to be the first Gram-positive, soil microorganism to be
completely sequenced and opened the era of functional
analysis of Gram-positive bacteria. The major resources
made available as a results of these efforts in B. subtilis
include datasets on transcriptome, proteome, secretome
and metabolome. These also include a collection of more
than 3000 mutants, vectors, tools and techniques for
rapid production of heterologous proteins [35,69,70].
Screening of metabolic (KEGG) and genomic (NCBI)
databases for the presence of enzymes [71] involved in
PHA biosynthesis reveals that genes for PhaA and PhaB
are observed to be present in almost all the sequenced
genomes of Bacillus except certain strains of B. megaterium
[29,72], B. thuringiensis, B. subtilis and Bacillus spp. (Table
1). However, quite a bit of variation is recorded in the case
of  phaC  gene and phaR. PhaC is frequently observed
largely in the members of B. cereus group, however, it's
conserved domain is absent or partially present in most
other Bacillus spp. The presence of conserved domain of
PhaR was largely partial or absent. In general B. subtilis
lacks genes related to PHA biosynthesis [1] providing
opportunity to circumvent the need to eliminate or reduce
the background effect caused due to homologous genes of
the host during heterologous gene expression. The con-
comitant presence of PHA biosynthesis and depolymeri-
zation system has proved beneficial for efficient
production of PHA [35]. Incidentally, B. subtilis does con-
tain phaZ encoding for PHA depolymerase.
Genome scale reconstruction
The basic quest in biotechnology is to construct microbial
strains capable of accomplishing the rapidly expanding
array of desired biotransformations [34]. The initial steps
towards enhancing product efficiency and recovery proc-
ess are to look for the presence of pathways that divert
fluxes towards undesirable products or compete for the
utilization of precursors and cofactors [73]. Genome scale
reconstruction of B. subtilis was converted into an in silicoMicrobial Cell Factories 2009, 8:38 http://www.microbialcellfactories.com/content/8/1/38
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Table 1: Conserved domains of enzymes for biosynthesis and depolymerization of polyhydroxyalkanoate of Bacillus species.
Description β-Keto thiolase Acetoacetyl reductase Polyhydroxyalkanoate
Synthase Depolymerase
PhaA PhaB PhaC PhaR PhaZ
Thiolase NADB FabG PhaC PRK
03918
DepA
Bacillus cereus 03BB102 Fa FF F P b F
B. cereus 03BB108 F F F F P F
B. cereus AH1134 F F F F Ac F
B. cereus AH187 F F F F P F
B. cereus AH820 F F F F P F
B. cereus ATCC 10987 F F F F P F
B. cereus ATCC 14579 F F F F A F
B. cereus B4264 F F F F A F
B. cereus E33L F F F F P F
B. cereus G9241 F F F F P F
B. cereus G9842 F F F F A F
B. cereus H3081.97 F F F F P F
B. cereus NVH0597-99 F F F F P F
B. cereus Q1 F F F F P F
B. cereus subsp. cytotoxis NVH 391–98 F F F F A F
B. cereus WF F F F P F
B. thuringiensis serovar israelensis ATCC 35646 F F F F A F
B. thuringiensis serovar konkukian str. 97-27 F F F F P F
B. thuringiensis str. Al Hakam F F F F P F
B. anthracis str. A0193 n/ad FF F PF
B. anthracis str. A0389 n/a F F F P F
B. anthracis str. A0442 n/a F F F P F
B. anthracis str. A0465 n/a F F F P F
B. anthracis str. A0488 n/a F F F P F
B. anthracis str. A2012 F F F F n/a F
B. anthracis str. Ames F F F F P F
B. anthracis str. 'Ames Ancestor' F F F F P F
B. anthracis str. Sterne F F F F P F
B. coagulans 36D1 F F F A A A
B. coahuilensis m4-4 F F F F A F
B. weihenstephanensis KBAB4 F F F F A F
B. amyloliquefaciens FZB42 F n/a n/a n/a n/a n/a
B. subtilis subsp. subtilis str. JH642 n/a n/a n/a n/a n/a n/a
B. subtilis
subsp. subtilis str. SMY
F F F n/a n/a n/a
B. subtilis subsp. subtilis str. 168 n/a Fe Fe n/a n/a n/aMicrobial Cell Factories 2009, 8:38 http://www.microbialcellfactories.com/content/8/1/38
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model to trace the metabolic pathways which can be veri-
fied through experimental works in B. subtilis [73,74]. This
can be executed with relatively high confidence with the
availability of databases on transcriptomes, proteomes
and metabolomes [73,74]. Biolog's Phenotype Microar-
ray™ technology enables phenotype analysis [74] of B.
subtilis for a wide range of C, N, P and sulphur sources. A
wide variety of C sources and their corresponding trans-
porters present in B. subtilis reflected on its high adaptabil-
ity to environmental conditions. The interesting part was
its inability to utilize glycine probably because of produc-
tion of H2O2, a toxic byproduct of glycine oxidase activity.
The absence of glycoxylate shunt in B. subtilis justifies the
observation that no growth is observed on acetate as sole
C source although NADH and ATP could be produced by
the metabolic network [74]. The phenotypes showing the
utilization of various substrates are indicative of the pres-
ence of corresponding pathways. In the work of Oh et al.,
[74] 350 intracellular metabolites were identified but only
160 were present in the model, which implies that a large
portion of B. subtilis metabolism is yet to be elucidated.
Synthetic genomics: a reductionist's approach
The urge to exploit microorganisms for maximum bene-
fits to human beings has emerged in creation of cells with
predictable behaviour. Genome reduction process for
building collection of knockout mutants has been initi-
ated for a wide range of bacteria such as Gram-positives –
B. subtilis (Firmicutes), Corynebacterium glutamicum (Actin-
obacteria), and Gram-negatives – E. coli K-12, Haemophilus
influenzae, P. aeruginosa, P. aeruginosa strain PA14 and Aci-
netobacter baylyi ADP1 (Gamma Proteobacteria) [73].
Efforts in this direction have been made with E. coli and B.
subtilis as model organisms (Table 2), for studying their
diverse biological features [32,75]. Since the most daunt-
ing task is to predict genes to be deleted without detrimen-
tal effect(s), Hoshimoto et al., began with constructing
and characterizing a series of large scale chromosomal
B. subtilis
subsp. subtilis str. NCIB 3610
FF F A A F
B. licheniformis F F F n/a n/a n/a
B. licheniformis ATCC 14580 F F F n/a n/a n/a
B. pumilus ATCC 7061 F F F A A A
B. pumilus SAFR-032 F F F A A A
B. halodurans C-125 F F F A A A
B. clausii KSM-K16 F F F A A A
B. megaterium n/a F F F A F
B. selenitireducens MLS10 F F F A A A
Bacillus sp. B14905 F F F A A A
Bacillus sp. C18 n/tf n/t n/t F n/t P
Bacillus sp. C19 n/t n/t n/t P n/t P
Bacillus sp. E13 n/t n/t n/t P n/t P
Bacillus sp. INT005 na F F F P F
Bacillus sp. NRRL B-14911 F F F F A A
Bacillus sp. SG-1 F F F A A A
a: Full domain present
b: Partial domain present
c: Domain absent
d: Not applicable
e: Enzyme was β-ketoacyl-acyl carrier protein reductase and the gene was fabG
f: Not traceable (due to partial sequencing)
Sequence analysis and pathway alignment of polyhydroxyalkanoate metabolism was done as described earlier [71]. Screening of Bacillus spp. in 
KEGG (Kyoto Encyclopedia of Genes and Genomes) http://www.genome.ad.jp database was performed for PHA biosynthesis enzymes β-ketoacyl-
CoA thiolase (PhaA-EC 2.3.1.9), an NADPH dependent Acetoacetyl-CoA reductase (PhaB-EC 1.1.1.36) and PHA synthase (PhaC-EC 2.3.1.41). The 
conserved domains for these enzymes were identified from RPS-BLAST [71] (reverse position-specific – basic local alignment search tool) at 
National Center for Biotechnology Information (NCBI) http://www.ncbi.nlm.nih.gov. Amino acid sequences of PhaA (GenBank accession no. 
AAP11875), PhaB (GenBank accession no. AAP08300), and PhaC (including PhaZ) (GenBank accession no. AAP08301) of Bacillus cereus ATCC 
14579, and PhaR (GenBank Accession no.: AAD05258) of B. megaterium were used as a queries against the Bacillus sequenced genome database 
using BLAST.
Table 1: Conserved domains of enzymes for biosynthesis and depolymerization of polyhydroxyalkanoate of Bacillus species. (Continued)Microbial Cell Factories 2009, 8:38 http://www.microbialcellfactories.com/content/8/1/38
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Table 2: Unique features of reduced genomes of Escherichia coli and Bacillus subtilis
Organism Parent strain Mutant strain Reduction in genome size DNA removed Unique 
characteristics
Ref
Mb %
Escherichia coli K-12 MG1655 Δ16 1.38 29.7 Large scale deletions Aberrant cell 
morphology
Increased doubling time
Changed nucleoid 
organization
[76]
E. coli K-12 MG1655 MDS42 0.71 15 Mobile DNA,
Cryptic virulence genes
Normal cell growth and 
protein expression, 
comparable to parental 
strain
MDS42 cells exhibit high 
electroporation 
efficiency and 
propagation of unstable 
plasmid
[77]
E. coli K-12 W3110 MGF-01 1.03 22 Biosynthesis genes for 
some amino acids, 
lipopolysaccharides and 
phosphor lipids
Transporter genes, ISs 
and toxin-antitoxin 
pairs
Growth was as rapid as 
the parental strain in 
minimal medium (M9) 
during exponential 
phase.
Mutant strain continued 
whereas wild type strain 
progressed to the 
stationary phase
MGF-01 secreted higher 
(2.44-fold) threonine 
compared to wild type 
strain
[75]
Bacillus subtilis 168 Δ6 0.32 7.7 Prophages – SPβ, PBSX
Prophage like 
sequences – pro1, pro3, 
skin (sigK intervening)
pks operon
No unique properties 
including AmyQ protein 
secretion
Increase in heterologous 
amylase secretion
[32]
B. subtilis 168 MGB469 0.50 12.5 All prophages
All prophage like 
sequences except pro7
pks and pps operons
Cell growth was normal
No beneficial properties 
were apparent
[79]
B. subtilis MGB469 MG1M 0.99a 24.7 All prophage
All prophage like 
sequences except pro7
pks, pps operon and 6 
deletions
Unstable phenotypes 
with regard to growth 
rate, cell morphology 
and recombinant protein 
production
[79]
B. subtilis MGB469 MGB874 0.87a 20.7 Eleven non essential 
gene cluster i.e. 
865genes
Genes essential for 
spore formation 
including spoIIIC and 
spoIVCB
Enhanced productivity of 
extracellular cellulase 
and protease
Reduced growth rate 
(30% in LB, 50% in SMM
compared with wild type 
B. subtilis 168 strain
Did not form spores
Improved efficiency of 
carbon source utilisation
[61]
a: with respect to B. subtilis 168 genomeMicrobial Cell Factories 2009, 8:38 http://www.microbialcellfactories.com/content/8/1/38
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deletion mutants of E. coli [76]. The 16 mutants of E. coli
K-12 strain MG1655 lacked 2.4–29.7% of the parental
chromosome. These deletions resulted in aberrant cell
shape, slow growth rate and modified nucleoid organiza-
tion. Mutants of E. coli MG1655 and W3110 with the
removal of mobile DNA, virulence genes and genes for
amino acids, lipopolysaccharides, transporters etc. exhib-
ited high electroporation efficiency [77] and higher threo-
nine secretion [75] compared to wild type strain. B. subtilis
the Gram-positive counter-part of the industrially impor-
tant E. coli has only 271 essential genes out of a 4.2 Mb
genome [78]. The optimization of Bacillus as cell factory
by deleting prophages, prophage-like regions and
polyketide synthase operon of B. subtilis amounted to
7.7% reduction in genome size equivalent to elimination
of 332 protein encoding genes [32]. Subsequent efforts by
Ara et al., 2007 lead to DNA deletion to the extent of
24.7% without any apparent benefits [79]. However,
Morimoto  et al., 2008 [61] have demonstrated that
genome reduction may create bacterial cells with practical
utility to industry – enhanced extracellular cellulase and
protease and improved efficiency to utilize a wide range of
C sources.
B. subtilis Δ6 has a few major advantages compared to con-
ventional B. subtilis strains. B. subtilis Δ6 lacks the BsuM
restriction-modification system. It confers advantages to
Δ6, since BsuM restriction reduces transformation effi-
ciency of B. subtilis with recombinant plasmids and is also
responsible for structural plasmid instability. It conse-
quently affects the application potential of plasmids for
high-level protein production [32]. This system can be
assisted by highly stable expression vectors developed for
the rapid purification of recombinant protein in B. subtilis
[80]. However, this cell factory engineering can be used to
re-insert genes of importance into the chromosome of B.
subtilis.
Horizontal Gene Transfer (HGT)
HGT plays an important role in the diversity and evolu-
tion of B. subtilis. Phage integration accounts for 16% of
the HGT regions in B. subtilis 168 [81]. Extensive HGT in
Bacillus sp. increases the chance of "easier" and extensive
manipulation. HGT from A+T rich islands can be accom-
plished by transposes. B. subtilis has comparatively more
stable chromosomal structure compared to other Bacillus
spp. particularly those of B. cereus group.  B. subtilis
genome shows 10 transposons and related rearrange-
ments compared to 112 such events in B. halodurans C-
125 chromosome [82]. In B. subtilis the ability to survive
in a wide range of environmental niches can be because of
large number of genes (586 equivalent to 10% of the
ORFs) related to SpoA, regulatory protein important for
initiating sporulation, genes encoding proteins involving
antibiotics and cell wall synthesis [63].
Manipulating carbon catabolite repression
In view of the fact that feedstock being a significant com-
ponent of manufacturing costs of PHA, maximizing the C
yield and reduced byproduct formation becomes a prior-
ity. The metabolic bottleneck for maximum yield of all
products is either stoichiometrically constrained or lim-
ited by energy. Sauer et al., [83] suggested that to improve
yields, it will be better to look for microorganisms and
processes that may provide the necessary energetic effi-
ciency [83]. They recommended either to use alternative C
substrates such as glycerol or sucrose (instead of glucose)
which have reduced or non-existing stoichiometric limita-
tions or go in for metabolic engineering [83]. For maxi-
mum efficiency and regulation of metabolic processes in
B. subtilis, an alternative C catabolite repression was sug-
gested since it doesn't possess cAMP [84]. A CcpA defec-
tive mutant of B. subtilis was found to grow at a slower rate
in minimal medium with glucose and ammonia as C and
N sources, in comparison to the wild type cells [84]. CcpA
represses the expression of citZ gene encoding citrate syn-
thase. This reaction involves condensation (utilization) of
acetyl-CoA with oxaloacetate [84]. Manipulation of CcpA
can enable larger availability of acetyl-CoA for PHA bio-
synthesis. Further, B. subtilis sporulates in response to
depletion of nutrients [64] and glucose [79]. Incidentally,
there is a conflict between PHA production and spore for-
mation, since both get induced under similar environ-
mental conditions. A non-spore forming strain (wild or
mutant) of Bacillus holds promise of better performance
[2]. So a knockout will enable it to grow vegetative and
make sporulation genes redundant. In fact, this mecha-
nism lead to increased cellulase activity in B. subtilis 168
[79]. Under laboratory conditions, it will be worth the
effort to knockout sporulations genes and make room for
re-introducing relevant genes, if necessary. Gram-positive
bacteria can produce copolymers of PHA from simple,
inexpensive and structurally un-related C sources. In con-
trast, Gram-negative bacteria depend upon expensive and
structurally related substrates for producing copolymers
of PHA [29].
Novel recovery system for PHA
Since PHA accumulates intracellularly, cell disruption is
indispensable to recover it. On an industrial scale, the
PHA recovery process involves the usage of a large amount
of chemical reagents and/or enzymes [2]. An efficient
recovery system implies reduced cost of production [85].
An optimum time to recover PHAs is immediately after
the C source gets exhausted and before the commence-
ment of degradation by depolymerase enzyme [86]. A
novel self disruption cell system has been developed in B.
megaterium. In this system, a gene cassette carrying the cell
lysis system (holin and endolysin of B. amyloliquefaciens
phage) [87] was inserted into the E. coli – B. subtilis shuttle
vector pX. In this expression system, xylR-xylA' target genesMicrobial Cell Factories 2009, 8:38 http://www.microbialcellfactories.com/content/8/1/38
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are induced by xylose but inhibited by glucose, which acts
as an anti-inducer [86]. It synchronizes the processes of
spontaneous cell lysis and substrate exhaustion, which
thus results in the release of accumulated PHAs [86]. The
efficiency of this regulatory process can be enhanced by
manipulating the YoeB, a cell wall-associated protein,
which gets induced in response to antibiotics stress. The
expression of yoeB in B. subtilis is under a xylose-inducible
promoter [88]. yoeB mutants display an increased rate of
autolysis in response to nutrient depletion and various
cell envelope stress conditions [88]. The process of autol-
ysis in B. subtilis 168 can be aided by mutating yoeB gene
and in the process making it independent of xylose regu-
lation.
Lacks Lipopolysaccharides
Gram-negative bacteria such as Ralstonia,  A. latus and
recombinant E. coli are among those which have been
exploited for industrial scale PHB production. The outer
cell membrane of most Gram-negative bacteria including
E. coli contains lipo-polysaccharides (LPS), which are
endotoxins [89] and are pryogenic in human beings [60].
The purification of byproducts including PHAs is compli-
cated due to the presence of endotoxins [60]. Since LPS
induces a strong immunogenic reaction, this feature is
undesirable for biomedical applications of the PHAs
[7,90]. A review on the toxic nature of LPS reveals that
cyanobacterial (Gram-positive bacteria) LPS are less toxic
compared to those produced by members of Entero-
bacteraceae [89]. B. subtilis offers the advantage of lacking
LPS and excreting proteins at a high rate into the medium
[61]. It thus stands a better chance as PHA producer for
biomedical applications [90].
Potential for producing hydrogen
The use of CO2 as a potential inexpensive renewable C
source can help in reducing PHA production cost [5]. Syn-
echococcus sp. MA19 was observed to produce 55% w/w
PHA from CO2 [91]. A. eutrophus was shown to accumu-
late PHA at the rate of 1.55 g/L/h, which was higher than
that recorded with cyanobacteria or photosynthetic bacte-
ria [92]. The strategy being proposed is that if hydrogen
(H2) production becomes cheap then R. eutropha can pro-
duce PHB from CO2 and oxidation of (H2), under dark
fermentative conditions [93]. Bacillus seems to meet the
requirements of this proposal. Bacillus  spp. such as B.
coagulans, B. licheniformis and B. subtilis have been shown
to evolve 1.5 to 2.36 mol H2/mol glucose [36]. Biowastes
rich in starch such as damaged wheat grains have been
employed as feed for generating H2 (45 to 64 L/kg Total
solids) by B. licheniformis and  B. subtilis [94]. More
recently, B. cereus strain EGU43 and B. thuringiensis strain
EGU45 have been reported to generate 0.63 mol of H2/
mol of glucose and upto 500 mg PHB/L [37].
Conclusion
B. subtilis as an organism for industrial scale production of
several fine chemicals is already established but not for
PHA production. A comparison of all the PHA producers
(Additional file 1, Table S1) reveals that the most versatile
PHA producers are Bacillus spp. Their abilities to produce
PHAs range from homopolymers to copolymers fromsim-
ple sugars to complex industrial wastes. It reflects on how
Bacillus can exploit its natural abilities to produce hydro-
lytic enzymes for easy metabolism of biowastes to be used
as inexpensive C source. Bacillus can be easily grown to
very high cell density of 70 g/L [41] and does not have a
major codon bias [29,58]. A recovery of around 70 to 80%
of bacterial dry matter as PHA production is potentially
sufficient for establishing an economically feasible proc-
ess [35]. In addition, the robust stress tolerant B. subtilis
lacking the toxic LPS, and permitting heterologous expres-
sion of self-lysing genes concomitant with completion of
PHA biosynthetic process (for efficient recovery), enable it
to be a strong contender in the future as an industrial PHA
producer.
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